Maestros electronics & Telecommunication System Limited has announced receiving a substantial purchase order from MD National Health Mission Jaipur under Regulation 30 of SEBI listing requirements. The order involves the supply of medical equipment specifically designed for healthcare applications in Rajasthan.

Order Details and Specifications

The purchase order encompasses the delivery of 378 pieces of METSL 12 Channels ECG Machine, a specialized medical device manufactured by the company. The contract has been structured with specific terms and conditions governing the supply arrangement.

Contract Terms and Governance

The agreement operates under comprehensive terms and conditions as stipulated in the marketplace framework. The contract between the seller and buyer covers the supply of goods in accordance with General Terms and Conditions, unless superseded by specific Special Terms and Conditions or additional terms applicable to the arrangement.

The order has been classified as a domestic contract, awarded by a domestic entity, indicating the company's strong position in the Indian healthcare equipment market. The execution timeline spans nearly two years, providing the company with a structured revenue stream through 2027.

Regulatory Compliance and Corporate Governance

The company has confirmed that neither the promoter nor promoter group has any interest in the entity that awarded the order, ensuring transparency in the business transaction. The contract does not fall within related party transactions, maintaining arm's length business practices.

The announcement was made through proper regulatory channels, with Managing Director Balkrishna Kamalakar Tendulkar signing the disclosure document on February 6, 2026. This order represents a significant addition to the company's order book and reinforces its presence in the medical equipment manufacturing sector.

Source:

Maestros Electronics & Telecommunications Systems Limited , a player in the medical and telemedicine segments, has announced its financial results for the second quarter of fiscal year 2026, revealing a mixed performance with declines in both revenue and profit.

Revenue and Profit Performance

For the quarter ended September 30, 2025, Maestros Electronics reported:

The company experienced a significant year-over-year decline in revenue, with Q2 FY2026 revenue from operations standing at ₹589.39 crore, down 19.6% from ₹733.00 crore in the same quarter of the previous year. This decrease in revenue was accompanied by a 30.0% drop in net profit, which fell to ₹151.75 crore from ₹216.88 crore in Q2 FY2025.

Half-Year Performance

For the half-year period ending September 30, 2025, Maestros Electronics achieved:

• Revenue: ₹1,632.46 crore
• Net Profit: ₹252.51 crore

Segment-wise Performance

Maestros Electronics operates in three main segments:

1. Electronics and Instrumentation
2. Medical
3. Telemedicine

The medical segment continued to be the primary revenue driver for the company.

Balance Sheet Highlights

As of September 30, 2025, the company reported:

• Total Assets: ₹4,854.35 crore
• Equity Share Capital: ₹551.02 crore
• Other Equity: ₹3,154.05 crore

Management Commentary

The Board of Directors approved these unaudited financial results at their meeting held on November 12, 2025. The company did not provide specific commentary on the factors contributing to the revenue and profit declines.

Conclusion

While Maestros Electronics & Telecommunications Systems Limited faced challenges in the second quarter of FY2026, with notable declines in both revenue and profit, the company maintains a strong balance sheet. The performance of its key segments, particularly medical equipment and telemedicine, will likely be areas of focus as the company moves forward.